Topic Review
Kinase Inhibition in Hematologic Neoplasms
Protein kinases (PK) are signaling regulators involved in various cellular functions including metabolism, cell cycle regulation, survival, and differentiation. Tumor dependence of continuous proliferative signals mediated through protein kinases overexpression instigated increased strategies of kinase inhibition in the oncologic practice over the last couple decades.
  • 481
  • 14 Oct 2021
Topic Review
Cellular and Interaction Diversity of Tumor Microenvironment
The tumor microenvironment is a complex network of various interactions between immune cells and non-cellular components such as the extracellular matrix, exosomes and interleukins. Moreover, tumor heterogeneity and its constant modification may alter the immunophenotype and become responsible for its resistance regarding the therapies applied However, it should be remembered that in a strongly immunosuppressive neoplastic microenvironment, the immune system cells undergo reprogramming and most often cease to fulfill their original function. Therefore, understanding what happens within the tumor microenvironment, and which mechanisms are responsible for tumor development and progression should let us know how cancer could protect itself against the immune system.
  • 480
  • 12 Jul 2022
Topic Review
Cholesterol Redistribution Regulates β-cell Insulin Biosynthesis and Secretion
Cholesterol, an essential component of the cellular membranes, exhibits multiple structural and functional roles, orchestrating a wide range of signalling pathways and cellular functions. The pancreatic β-cells rely on cholesterol for their survival, proliferation, and functional maturation. Intracellular cholesterol imbalance is a tremendous burden to β-cells as this condition disables the cells from adequately delivering the sterol to its final destinations, resulting in altered plasma membrane organization, impaired mitochondrial activity, reduced insulin granule maturation, and glucose-stimulated insulin secretion. To maintain cholesterol homeostasis, β-cells have evolved a sophisticated machinery that not only controls the lipid biosynthesis or influx/efflux but also its redistribution among the different organelles. The mechanisms by which β-cells sense and shuttle the lipids across different membrane compartments are still largely unexplored.
  • 480
  • 02 Feb 2023
Topic Review
Hematopoietic Stem Cells and Metabolic Program
Hematopoietic stem cells (HSCs) in bone marrow continuously supply a large number of blood cells throughout life in collaboration with hematopoietic progenitor cells (HPCs). HSCs and HPCs are thought to regulate and utilize intracellular metabolic programs to obtain metabolites, such as adenosine triphosphate (ATP), which is necessary for various cellular functions. The metabolic programs of tissue stem/progenitor cells and their underlying molecular mechanisms have been elucidated using a variety of metabolic analysis methods.
  • 480
  • 05 Jan 2023
Topic Review
Thyroid Cancer Stem-Like Cells
Thyroid cancer (TC) is the most common endocrine malignancy. Recent progress in thyroid cancer biology revealed a certain degree of intratumoral heterogeneity, highlighting the coexistence of cellular subpopulations with distinct proliferative capacities and differentiation abilities. Among those subpopulations, cancer stem-like cells (CSCs) are hypothesized to drive TC heterogeneity, contributing to its metastatic potential and therapy resistance. CSCs principally exist in tumor areas with specific microenvironmental conditions, the so-called stem cell niches. In particular, in thyroid cancer, CSCs’ survival is enhanced in the hypoxic niche, the immune niche, and some areas with specific extracellular matrix composition.
  • 479
  • 23 Jun 2021
Topic Review
Lipid Metabolism and Acylglycerolphosphate Acyltransferases (AGPATs) in Cancer
Alter lipid metabolism is an emerging hallmark of cancer. The conversion of fatty acids to neutral triacylglycerides (TAG), plays a central role in this adaptive process.  Acylglycerolphosphate acyltransferases (AGPATs)/lysophosphatidic acid acyltransferases (LPAATs) are a family of enzymes that catalyze the synthesis of phosphatidic acid (PA), an intermediate in TAG synthesis, a signaling molecule, and a precursor of phospholipids. Importantly, the expression of AGPATs has been linked to diverse physiological and pathological phenotypes, including cancer.
  • 479
  • 20 Jan 2022
Topic Review
Microglial Endocannabinoid Signalling in Alzheimer’s Disease
Chronic inflammation in Alzheimer’s disease (AD) has been recently identified as a major contributor to disease pathogenesis. Once activated, microglial cells, which are brain-resident immune cells, exert several key actions, including phagocytosis, chemotaxis, and the release of pro- or anti-inflammatory mediators, which could have opposite effects on brain homeostasis, depending on the stage of disease and the particular phenotype of microglial cells. The endocannabinoids (eCBs) are pleiotropic bioactive lipids increasingly recognized for their essential roles in regulating microglial activity both under normal and AD-driven pathological conditions. 
  • 478
  • 25 May 2022
Topic Review
Enhancer RNAs (eRNAs) in Cancer
Enhancer RNAs (eRNAs) are non-coding RNAs (ncRNAs) transcribed in enhancer regions. They play an important role in transcriptional regulation, mainly during cellular differentiation. eRNAs are tightly tissue- and cell-type specific and are induced by specific stimuli, activating promoters of target genes in turn. eRNAs usually have a very short half-life but in some cases, once activated, they can be stably expressed and acquire additional functions. Due to their critical role, eRNAs are often dysregulated in cancer and growing number of interactions with chromatin modifiers, transcription factors, and splicing machinery have been described.
  • 478
  • 19 Apr 2022
Topic Review
IPSC-Based PDAC Models and Immunotherapies
Advances in the treatment of pancreatic ductal adenocarcinoma (PDAC) using neoadjuvant chemoradiotherapy, chemotherapy, and immunotherapy have had minimal impact on the overall survival of patients. A general lack of immunogenic features and a complex tumor microenvironment (TME) are likely culprits for therapy refractoriness in PDAC. Induced pluripotent stem cells (iPSCs) should be explored as a means to advance the treatment options for PDAC, by providing representative in vitro models of pancreatic cancer development. In addition, iPSCs could be used for tailor-made cellular immunotherapies or as a source of tumor-associated antigens in the context of vaccination.
  • 478
  • 29 Mar 2022
Topic Review
Application of Calcitriol in Breast Cancer
Calcitriol represents the most active VD metabolite and hormonal form, which modulates calcium homeostasis through actions on the kidney, bone, and intestinal tract. However, calcitriol is also known for its potent anticancer effects. In particular, calcitriol inhibits breast cancer cells proliferation and tumorigenesis.
  • 478
  • 03 Dec 2021
  • Page
  • of
  • 161
Video Production Service